Skip to main content
Erschienen in: Current Cardiology Reports 12/2020

01.12.2020 | Valvular Heart Disease (TL Kiefer, Section Editor)

Radiation-Associated Valvular Disease

verfasst von: Samantha Xu, Eoin Donnellan, Milind Y. Desai

Erschienen in: Current Cardiology Reports | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Radiation-associated valvular disease (RAVD) is characterized by late valvular manifestations following radiation exposure to the mediastinum. Review of current guidelines was performed to examine best practices to reduce risk and optimize outcomes in this patient population.

Recent Findings

Early and consistent screening and comprehensive and careful planning are critical in managing RAVD. Due to long latency periods, serial screening and targeted evaluation of risk factors are essential to early detection. Varying and complex presentations of RAVD require an integrated team of experienced specialists equipped with multimodality imaging-based screening protocols to stratify risk, plan intervention, and evaluate treatment response.

Summary

Patients with valvular manifestations associated with radiation therapy call for an individualized plan of care involving longitudinal multimodality imaging-based screening and experienced decision-making regarding timing and strategy of intervention to improve patient outcomes.
Literatur
1.
Zurück zum Zitat • Desai MY, Jellis CL, Kotecha R, Johnston DR, Griffin BP. Radiation-associated cardiac disease: a practical approach to diagnosis and management. JACC Cardiovasc Imaging. 2018;11:1132–49 Provided a comprehensive overview of the disease and pragmatic approaches to diagnosis and management.CrossRefPubMed • Desai MY, Jellis CL, Kotecha R, Johnston DR, Griffin BP. Radiation-associated cardiac disease: a practical approach to diagnosis and management. JACC Cardiovasc Imaging. 2018;11:1132–49 Provided a comprehensive overview of the disease and pragmatic approaches to diagnosis and management.CrossRefPubMed
2.
3.
Zurück zum Zitat Donnellan E, Phelan D, Mccarthy CP, Collier P, Desai M, Griffin B. Radiation-induced heart disease: a practical guide to diagnosis and management. Cleve Clin J Med. 2016;83:914–22.CrossRefPubMed Donnellan E, Phelan D, Mccarthy CP, Collier P, Desai M, Griffin B. Radiation-induced heart disease: a practical guide to diagnosis and management. Cleve Clin J Med. 2016;83:914–22.CrossRefPubMed
4.
Zurück zum Zitat Donnellan E, Jellis CL, Griffin BP. Radiation-associated cardiac disease: from molecular mechanisms to clinical management. Curr Treat Options Cardiovasc Med. 2019;21(5):22.CrossRefPubMed Donnellan E, Jellis CL, Griffin BP. Radiation-associated cardiac disease: from molecular mechanisms to clinical management. Curr Treat Options Cardiovasc Med. 2019;21(5):22.CrossRefPubMed
5.
Zurück zum Zitat Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117:412–8.CrossRefPubMed Galper SL, Yu JB, Mauch PM, Strasser JF, Silver B, LaCasce A, et al. Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation. Blood. 2011;117:412–8.CrossRefPubMed
6.
Zurück zum Zitat Emami B, Lyman J, Brown A, Cola L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–22.CrossRefPubMed Emami B, Lyman J, Brown A, Cola L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–22.CrossRefPubMed
7.
Zurück zum Zitat Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27:766–73.CrossRefPubMed Veinot JP, Edwards WD. Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. Hum Pathol. 1996;27:766–73.CrossRefPubMed
8.
Zurück zum Zitat •• Desai MY, Windecker S, Lancellotti P, et al. Prevention, diagnosis, and management of radiation-associated cardiac disease: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;74:905–27 A landmark scientific statement on radiation heart disease from a panel of experts.CrossRefPubMed •• Desai MY, Windecker S, Lancellotti P, et al. Prevention, diagnosis, and management of radiation-associated cardiac disease: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;74:905–27 A landmark scientific statement on radiation heart disease from a panel of experts.CrossRefPubMed
9.
Zurück zum Zitat Hayashi T, Morishita Y, Kubo Y, et al. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med. 2005;79:129–36. Hayashi T, Morishita Y, Kubo Y, et al. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med. 2005;79:129–36.
10.
Zurück zum Zitat Nadlonek NA, Weyant MJ, Yu JA, Cleveland JC Jr, Reece TB, Meng X, et al. Radiation induces osteogenesis in human aortic valve interstitial cells. J Thorac Cardiovasc Surg. 2012;144:1466–70.CrossRefPubMedPubMedCentral Nadlonek NA, Weyant MJ, Yu JA, Cleveland JC Jr, Reece TB, Meng X, et al. Radiation induces osteogenesis in human aortic valve interstitial cells. J Thorac Cardiovasc Surg. 2012;144:1466–70.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76:S77–85.CrossRefPubMed Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys. 2010;76:S77–85.CrossRefPubMed
12.
Zurück zum Zitat Amromin GD, Gildenhorn HL, Solomon RD, Nadkarni BB, Jacobs ML. The synergism of X-irradiation and cholesterol-fat feeding on the development of coronary artery lesions. J Atheroscler Res. 1964;4:325–34.CrossRefPubMed Amromin GD, Gildenhorn HL, Solomon RD, Nadkarni BB, Jacobs ML. The synergism of X-irradiation and cholesterol-fat feeding on the development of coronary artery lesions. J Atheroscler Res. 1964;4:325–34.CrossRefPubMed
13.
Zurück zum Zitat Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Wells WA, Winter JN, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. N Engl J Med. 2012;366:399–408.CrossRefPubMed Meyer RM, Gospodarowicz MK, Connors JM, Pearcey RG, Wells WA, Winter JN, et al. ABVD alone versus radiation-based therapy in limited-stage Hodgkin’s lymphoma. N Engl J Med. 2012;366:399–408.CrossRefPubMed
14.
Zurück zum Zitat Tamura A, Takahara Y, Mogi K, Katsumata M. Radiation-induced valvular disease is the logical consequence of irradiation. Gen Thorac Cardiovasc Surg. 2007;55:53–6.CrossRefPubMed Tamura A, Takahara Y, Mogi K, Katsumata M. Radiation-induced valvular disease is the logical consequence of irradiation. Gen Thorac Cardiovasc Surg. 2007;55:53–6.CrossRefPubMed
15.
Zurück zum Zitat Desai MY, Wu W, Masri A, Popovic ZB, Agarwal S, Smedira NG, et al. Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. Ann Thorac Surg. 2014;97:1348–55.CrossRefPubMed Desai MY, Wu W, Masri A, Popovic ZB, Agarwal S, Smedira NG, et al. Increased aorto-mitral curtain thickness independently predicts mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. Ann Thorac Surg. 2014;97:1348–55.CrossRefPubMed
16.
Zurück zum Zitat Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid , subclavian , and coronary artery disease treated with radiation therapy. Jama. 2003;290:2831–387.CrossRefPubMed Hull MC, Morris CG, Pepine CJ, Mendenhall NP. Valvular dysfunction and carotid , subclavian , and coronary artery disease treated with radiation therapy. Jama. 2003;290:2831–387.CrossRefPubMed
17.
Zurück zum Zitat Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42:743–9.CrossRefPubMed Heidenreich PA, Hancock SL, Lee BK, Mariscal CS, Schnittger I. Asymptomatic cardiac disease following mediastinal irradiation. J Am Coll Cardiol. 2003;42:743–9.CrossRefPubMed
18.
Zurück zum Zitat Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013;14(8):721–40.CrossRefPubMed Lancellotti P, Nkomo VT, Badano LP, Bergler-Klein J, Bogaert J, Davin L, et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2013;14(8):721–40.CrossRefPubMed
19.
Zurück zum Zitat Kamdar AR, Meadows TA, Roselli EE, Gorodeski EZ, Curtin RJ, Sabik JF, et al. Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg. 2008;85:1239–45.CrossRefPubMed Kamdar AR, Meadows TA, Roselli EE, Gorodeski EZ, Curtin RJ, Sabik JF, et al. Multidetector computed tomographic angiography in planning of reoperative cardiothoracic surgery. Ann Thorac Surg. 2008;85:1239–45.CrossRefPubMed
20.
Zurück zum Zitat Desai MY, Karunakaravel K, Wu W, Agarwal S, Smedira NG, Lytle BW, et al. Pulmonary fibrosis on multidetector computed tomography and mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2014;148:475–81.CrossRefPubMed Desai MY, Karunakaravel K, Wu W, Agarwal S, Smedira NG, Lytle BW, et al. Pulmonary fibrosis on multidetector computed tomography and mortality in patients with radiation-associated cardiac disease undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2014;148:475–81.CrossRefPubMed
21.
Zurück zum Zitat Otto CM, Kumbhani DJ, Alexander KP, et al. ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2017;2017(69):1313–46.CrossRef Otto CM, Kumbhani DJ, Alexander KP, et al. ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on clinical expert consensus documents. J Am Coll Cardiol. 2017;2017(69):1313–46.CrossRef
22.
Zurück zum Zitat Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, van der Meer P, et al. Cardio-oncology services: rationale, organization, and implementation. Eur Heart J. 2019;40:1756–63.CrossRefPubMed Lancellotti P, Suter TM, López-Fernández T, Galderisi M, Lyon AR, van der Meer P, et al. Cardio-oncology services: rationale, organization, and implementation. Eur Heart J. 2019;40:1756–63.CrossRefPubMed
23.
Zurück zum Zitat Donis N, Oury C, Moonen M, Lancellotti P. Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies. Expert Opin Pharmacother. 2018;19:431–42.CrossRefPubMed Donis N, Oury C, Moonen M, Lancellotti P. Treating cardiovascular complications of radiotherapy: a role for new pharmacotherapies. Expert Opin Pharmacother. 2018;19:431–42.CrossRefPubMed
24.
Zurück zum Zitat Van Der Veen SJ, Ghobadi G, De Boer RA, et al. ACE inhibition attenuates radiation-induced cardiopulmonary damage. Radiother Oncol. 2015;114:96–103.CrossRefPubMed Van Der Veen SJ, Ghobadi G, De Boer RA, et al. ACE inhibition attenuates radiation-induced cardiopulmonary damage. Radiother Oncol. 2015;114:96–103.CrossRefPubMed
25.
Zurück zum Zitat Haydont V, Bourgier C, Pocard M, Lusinchi A, Aigueperse J, Mathe D, et al. Pravastatin inhibits the rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res. 2007;13:5331–40.CrossRefPubMed Haydont V, Bourgier C, Pocard M, Lusinchi A, Aigueperse J, Mathe D, et al. Pravastatin inhibits the rho/CCN2/extracellular matrix cascade in human fibrosis explants and improves radiation-induced intestinal fibrosis in rats. Clin Cancer Res. 2007;13:5331–40.CrossRefPubMed
26.
Zurück zum Zitat Gürses I, Özeren M, Serin M, Yücel N, Erkal HŞ. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract. 2014;210:863–71.CrossRefPubMed Gürses I, Özeren M, Serin M, Yücel N, Erkal HŞ. Histopathological evaluation of melatonin as a protective agent in heart injury induced by radiation in a rat model. Pathol Res Pract. 2014;210:863–71.CrossRefPubMed
27.
Zurück zum Zitat Gu A, Jie Y, Sun L, Zhao S, Mingyan E, You Q. RhNRG-1β protects the myocardium against irradiation-induced damage via the ErbB2-ERK-SIRT1 signaling pathway. PLoS One. 2015;10:e0137337.CrossRefPubMedPubMedCentral Gu A, Jie Y, Sun L, Zhao S, Mingyan E, You Q. RhNRG-1β protects the myocardium against irradiation-induced damage via the ErbB2-ERK-SIRT1 signaling pathway. PLoS One. 2015;10:e0137337.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat GHARAGOZLOO F, CLEMENTS IP, MULLANY CJ. Use of the internal mammary artery for myocardial revascularization in a patient with radiation-induced coronary artery disease. Mayo Clin Proc. 1992;67(11):1081–4.CrossRefPubMed GHARAGOZLOO F, CLEMENTS IP, MULLANY CJ. Use of the internal mammary artery for myocardial revascularization in a patient with radiation-induced coronary artery disease. Mayo Clin Proc. 1992;67(11):1081–4.CrossRefPubMed
29.
Zurück zum Zitat •• Wu W, Masri A, Popovic ZB, et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476–84 Highlighted the high risk nature of open heart surgery in patients with radiation heart disease.CrossRefPubMed •• Wu W, Masri A, Popovic ZB, et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476–84 Highlighted the high risk nature of open heart surgery in patients with radiation heart disease.CrossRefPubMed
30.
Zurück zum Zitat Desai MY, Cremer PC, Schoenhagen P. Thoracic aortic calcification: diagnostic, prognostic, and management considerations. JACC Cardiovasc Imaging. 2018;11:1012–26.CrossRefPubMed Desai MY, Cremer PC, Schoenhagen P. Thoracic aortic calcification: diagnostic, prognostic, and management considerations. JACC Cardiovasc Imaging. 2018;11:1012–26.CrossRefPubMed
31.
Zurück zum Zitat Crestanello JA, McGregor CGA, Danielson GK, et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2004;78:826–31.CrossRefPubMed Crestanello JA, McGregor CGA, Danielson GK, et al. Mitral and tricuspid valve repair in patients with previous mediastinal radiation therapy. Ann Thorac Surg. 2004;78:826–31.CrossRefPubMed
32.
Zurück zum Zitat Wu W, Masri A, Popovic ZB, Smedira NG, Lytle BW, Marwick TH, et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476–85.CrossRefPubMed Wu W, Masri A, Popovic ZB, Smedira NG, Lytle BW, Marwick TH, et al. Long-term survival of patients with radiation heart disease undergoing cardiac surgery: a cohort study. Circulation. 2013;127:1476–85.CrossRefPubMed
33.
Zurück zum Zitat • Donnellan E, Alashi A, Johnston DR, et al. Outcomes of patients with mediastinal radiation-associated mitral valve disease undergoing cardiac surgery. Circulation. 2019;140:1288–90 The first study to investigate outcomes of mitral valve interventions in these patients.CrossRefPubMed • Donnellan E, Alashi A, Johnston DR, et al. Outcomes of patients with mediastinal radiation-associated mitral valve disease undergoing cardiac surgery. Circulation. 2019;140:1288–90 The first study to investigate outcomes of mitral valve interventions in these patients.CrossRefPubMed
34.
Zurück zum Zitat Donnellan E, Masri A, Johnston DR, et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6:e005396.CrossRefPubMedPubMedCentral Donnellan E, Masri A, Johnston DR, et al. Long-term outcomes of patients with mediastinal radiation-associated severe aortic stenosis and subsequent surgical aortic valve replacement: a matched cohort study. J Am Heart Assoc. 2017;6:e005396.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Donnellan E, Griffin BP, Johnston DR, Popovic ZB, Alashi A, Kapadia SR, et al. Rate of progression of aortic stenosis and its impact on outcomes in patients with radiation-associated cardiac disease: a matched cohort study. JACC Cardiovasc Imaging. 2018;11:1072–80.CrossRefPubMed Donnellan E, Griffin BP, Johnston DR, Popovic ZB, Alashi A, Kapadia SR, et al. Rate of progression of aortic stenosis and its impact on outcomes in patients with radiation-associated cardiac disease: a matched cohort study. JACC Cardiovasc Imaging. 2018;11:1072–80.CrossRefPubMed
36.
Zurück zum Zitat Donnellan E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, Aguilera J, Kapadia SR, et al. Outcomes of patients with mediastinal radiation-associated severe aortic stenosis undergoing transcatheter aortic valve replacement. Circulation. 2018;138(16):1752–4.CrossRefPubMed Donnellan E, Krishnaswamy A, Hutt-Centeno E, Johnston DR, Aguilera J, Kapadia SR, et al. Outcomes of patients with mediastinal radiation-associated severe aortic stenosis undergoing transcatheter aortic valve replacement. Circulation. 2018;138(16):1752–4.CrossRefPubMed
37.
Zurück zum Zitat Zhang D, Guo W, Al-Hijji MA, et al. Outcomes of patients with severe symptomatic aortic valve stenosis after chest radiation: transcatheter versus surgical aortic valve replacement. J Am Heart Assoc. 2019;8:e012110.PubMedPubMedCentral Zhang D, Guo W, Al-Hijji MA, et al. Outcomes of patients with severe symptomatic aortic valve stenosis after chest radiation: transcatheter versus surgical aortic valve replacement. J Am Heart Assoc. 2019;8:e012110.PubMedPubMedCentral
38.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–91.CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–91.CrossRef
Metadaten
Titel
Radiation-Associated Valvular Disease
verfasst von
Samantha Xu
Eoin Donnellan
Milind Y. Desai
Publikationsdatum
01.12.2020
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 12/2020
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-020-01411-0

Weitere Artikel der Ausgabe 12/2020

Current Cardiology Reports 12/2020 Zur Ausgabe

Psychological Aspects of Cardiovascular Diseases (A Steptoe, Section Editor)

Shock to the Heart: Psychosocial Implications and Applications of Sudden Cardiac Death in the Young

Management of Acute Coronary Syndromes (H Jneid, Section Editor)

Management of Patients with Acute Coronary Syndrome and Cancer

Public Health Policy (E Klodas, Section Editor)

Strategies for Improving Nutrition in Inner-City Populations

Congenital Heart Disease (RA Krasuski and G Fleming, Section Editors)

The Future of Paediatric Heart Interventions: Where Will We Be in 2030?

Cardio-Oncology (T Neilan, Section Editor)

COVID-19 and Cardiovascular Health Among Patients with Cancer

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.